跳至主要内容
临床试验/IRCT1138901181414N11
IRCT1138901181414N11已完成3 期

Comparison of the short & long term effects and side effects of Samen recombinant human growth hormone & NOVO growth hormone in children with growth hormone deficiency: double-blind randomized clinical trial study

Pharmacy CO. Samen0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7 years 至 13 years(—)
性别
All

入选标准

  • inclusion criteria:
  • 1-Pre-pubertal stage
  • 2-Height standard deviation score<-3
  • 3-Insulin growth factor-1 inappropriate for age & sex (low)
  • 4-Growth hormone level post stimulating test by clonidine <10 ng/ml
  • 5-Rule out of the other causes of growth hormone deficiency
  • exclusion criteria:
  • 1-Acute disorders such as seizure, infection diseases
  • 2-Turner syndrome
  • 3-Chronic kidney disease
  • 4-Usage prednisolone

排除标准

  • 未提供

研究者

发起方
Pharmacy CO. Samen

相似试验

Comparison of the clinical & treatment effects of... | 临床试验